U
University Hospital in Krakow | Neurology Department
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Empagliflozin
Pacritinib
Gabapentin
BI456906
Dabigatran Etexilate
Methylprednisolone
BI 765845
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
1 of 8 total trials
This study (study ID PAC203 North America; PAC303 ex-North America) is evaluating 200 mg BID of pacritinib compared to physician's choice (P/C) thera...
Enrolling
Post-essential Thrombocythemia Myelofibrosis
Post-polycythemia Vera Myelofibrosis
Drug: Physician's Choice medications
Drug: Pacritinib
Trial sponsors
J
M
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems